iron chelator

OTHER2 trials

Sponsors

Novartis Pharmaceuticals, Radboud Universitair Medisch Centrum

Conditions

Chronic Iron Overloadcerebral spasm delayed cerebral ischemia

Unknown Phase

Deferoxamine in Aneurysmal Subarachnoid Hemorrhage trial

Radboud Universitair Medisch Centrumcerebral spasm delayed cerebral ischemia

Target: 40Updated: 2024-02-28

Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload

CompletedNCT05440487

Novartis PharmaceuticalsChronic Iron Overload

Start: 2015-09-15End: 2021-10-29Updated: 2022-10-21